Taysha Gene Therapies, Inc. Common Stock

TSHA US8776191061

💰
Capitalization
Small-cap

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

🔗
Website
https://www.tayshagtx.com
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
7
🙍
Insiders
3
Person Price Shares Total Published Completed
Nagendran Sukumar
PR 		3.23
USD 		200,000
Sold 		646,000
USD 		10/09/2025 10/09/2025
Nagendran Sukumar
PR 		2.85
USD 		57,054
Sold 		162,604
USD 		21/08/2025 21/08/2025
Alam Kamran
CFO 		2.85
USD 		54,491
Sold 		155,299
USD 		21/08/2025 21/08/2025
Manning Paul B
O 		2.75
USD 		750,000
Bought 		2,062,500
USD 		30/05/2025 30/05/2025
Manning Paul B
O 		2.75
USD 		750,000
Bought 		2,062,500
USD 		30/05/2025 30/05/2025
Manning Paul B
O 		2.25
USD 		1,333,333
Bought 		2,999,999
USD 		27/06/2024 27/06/2024
Manning Paul B
 1.63
USD 		100,000
Bought 		163,000
USD 		17/11/2023 17/11/2023
Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Taysha Gene Therapies, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Last 52W Low 52W High All-Time Low All-Time High β
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Manning Paul B 4 7,287,999.25 1,821,999.81 17/11/2023 30/05/2025
Nagendran Sukumar 2 808,603.90 404,301.95 21/08/2025 10/09/2025
Alam Kamran 1 155,299.35 155,299.35 21/08/2025 21/08/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.